Nu Skin Enterprises, Inc.
NUS · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $1 | $2 | $3 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $1 | $1 | $1 |
| Enterprise Value | $1 | $1 | $2 | $3 |
| Revenue | $2 | $2 | $2 | $3 |
| % Growth | -12% | -11.5% | -17.4% | – |
| Gross Profit | $1 | $1 | $2 | $2 |
| % Margin | 68.2% | 68.9% | 71.7% | 75% |
| EBITDA | -$0 | $0 | $0 | $0 |
| % Margin | -4.6% | 10.3% | 7.9% | 13.7% |
| Net Income | -$0 | $0 | $0 | $0 |
| % Margin | -8.5% | 0.4% | 4.7% | 5.5% |
| EPS Diluted | -2.95 | 0.17 | 2.07 | 2.86 |
| % Growth | -1,835.3% | -91.8% | -27.6% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |